Modified polysaccharide adjuvant-protein antigen conjugates, the preparation thereof and the use thereof
AssigneeGalenica Pharmaceuticals, Inc.
InventorDante J. Marciani
Life of this patent
Estimating the term…
Loading patent…
AssigneeGalenica Pharmaceuticals, Inc.
InventorDante J. Marciani
Estimating the term…
The present invention is directed to chemical conjugates (herein referred to as polysaccharide adjuvant-antigen conjugates) that have a polysaccharide backbone capable of binding to the cell surface of Antigen Presenting Cells (APCs), to which is covalently attached (a) one or more molecules having a stable carbonyl group (i.e. an aldehyde and ketone group that is capable of reacting with amino groups to form an imine or Schiff base), and (b) one or more polypeptides or peptides that are capable of eliciting an immunogenic response when covalently attached to polysaccharide backbone. Also disclosed are methods for making the conjugates and methods of using the conjugates to enhance the potentiation of an immune response in a mammal. Also disclosed is a method of vaccination, and pharmaceutical and veterinary compositions comprising one or more of the polysaccharide adjuvant-antigen conjugates of the present invention.
A polysaccharide adjuvant-protein antigen conjugate, wherein said conjugate is represented by the formula:
A polysaccharide adjuvant-antigen conjugate, comprising:
Dependencies are inferred from the claim text.